Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange

Stock Information for IntelliPharmaCeutics International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About IntelliPharmaCeutics International Inc.

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Intellipharmaceutics Announces Cease Trade Order
Canadian Investment Regulatory Organization Trading Halt - IPCI
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
Intellipharmaceutics International Inc. Announces Stock Option Grant
Intellipharmaceutics Announces Third Quarter 2023 Results
Intellipharmaceutics Reports Director Election Results
Intellipharmaceutics Announces Second Quarter 2023 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.